CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.

1:14-cv-00777

Overview

Case Number 1:14-cv-00777
Filing Date 2014-06-19
Status Terminated
Termination Date 2015-09-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Mylan Technologies Inc. NPE (Patent Assertion Entity)

Represented By

7 Attorneys Listed

Jayadeep R. Deshmukh

Email: jdeshmukh@kasowitz.com

William R. Zimmerman

Email: bill.zimmerman@knobbe.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Jonathan E. Bachand

Email: jonathan.bachand@knobbe.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Jared C. Bunker

Email: Jared.Bunker@knobbe.com

William O. Adams

Email: William.adams@knobbe.com

Mylan Pharmaceuticals Inc. Operating Company

Represented By

8 Attorneys Listed

Jayadeep R. Deshmukh

Email: jdeshmukh@kasowitz.com

William R. Zimmerman

Email: bill.zimmerman@knobbe.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Jonathan E. Bachand

Email: jonathan.bachand@knobbe.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Jared C. Bunker

Email: Jared.Bunker@knobbe.com

William O. Adams

Email: William.adams@knobbe.com

Novartis AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Novartis Pharmaceuticals Corporation Operating Company

Represented By

4 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Nicholas N. Kallas

Email: nkallas@venable.com

Christopher E. Loh

Email: cloh@venable.com

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Plaintiff

Novartis Pharma AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Counter Claimant

Mylan Inc. Operating Company

Represented By

9 Attorneys Listed

Jayadeep R. Deshmukh

Email: jdeshmukh@kasowitz.com

William R. Zimmerman

Email: bill.zimmerman@knobbe.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Andrea L. Cheek

Email: Andrea.Cheek@knobbe.com

Jonathan E. Bachand

Email: jonathan.bachand@knobbe.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Jared C. Bunker

Email: Jared.Bunker@knobbe.com

William O. Adams

Email: William.adams@knobbe.com

Counter Defendant

LTS Lohmann Therapie-Systeme AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 8 proceedings
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (12 found):
PTAB: 4 U.S. Courts: 8
USPTO PTAB Trial 2014-11-13
IPR2015-00268

Mylan Pharmaceuticals Inc. et al. v. Novartis AG et al.

U.S. Continuation Sibling (6335031)
Status: Final Written Decision
USPTO PTAB Trial 2014-11-13
IPR2015-00265

Mylan Pharmaceuticals Inc. et al. v. Novartis AG et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2014-04-02
IPR2014-00550

Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.

U.S. Continuation Sibling (6335031)
Status: Final Written Decision
USPTO PTAB Trial 2014-04-02
IPR2014-00549

Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2015-11-05
1:15-cv-01025

Novartis Pharmaceuticals Corporation v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2015-11-05
1:15-cv-01026

Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories, Ltd.

Asserted Patent
Status: DED
U.S. District Court 2014-01-30
1:14-cv-00111

Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-04-03
1:13-cv-00527

Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-03-07
1:13-cv-00370

Novartis Pharmaceuticals Corporation v. Alvogen Pine Brook Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-03-07
1:13-cv-00371

Novartis Pharmaceuticals Corporation v. Actavis Inc.

Asserted Patent
Status: DED
U.S. District Court 2011-11-09
1:11-cv-01112

Novartis Pharmaceuticals Corporation v. Watson Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2011-11-03
1:11-cv-01077

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6316023
TTS containing an antioxidant
Filed: 2000-12-20
Issued: 2001-11-13
Expired (Term Ended)
Expires: 2020-12-20
US6335031
TTS containing an antioxidant
Filed: 1999-04-14
Issued: 2002-01-01
Expired (Term Ended)
Expires: 2019-04-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

15

Dispositive

11

Granted

2

Denied

1

Pending / Review

12

Motions by Category

Procedural / Extension Motion 3 Motion to Dismiss 11 Motion to Stay 1

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Mylan Technologies Inc.. (Attachments: # 1 Text of Proposed Order)(Moore, David) (Entered:...
Entry #57 • 2015-03-30 Document →
Motion to Dismiss Pending / Under Review
[SEALED] OPENING BRIEF in Support re 57 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Mylan Technologies Inc..Answering Brief/Response due...
Entry #58 • 2015-03-30 Document →
Motion to Dismiss Pending / Under Review
[SEALED] DECLARATION of Frank Mullery re 57 MOTION to Dismiss, by Mylan Technologies Inc.. (Moore, David) Modified on 3/31/2015 (nms). (Entered: 03/30/2015)
Entry #59 • 2015-03-30 Document →
Motion to Dismiss Denied
ORDER Denying Mylan Pharmaceuticals Inc.'s Motion to Dismiss (D.I. 14 ); DISMISSING without prejudice Mylan Inc.'s Motion to Dismiss. Plaintiffs are permitted s...
Entry #50 • 2015-03-16 Document →
Motion to Dismiss Pending / Under Review
ORDER regarding the request to argue the effect of Acorda and AstraZeneca on the pending motion to dismiss (see Order for further directives). Signed by Judge R...
Entry #35 • 2015-01-22 Document →
Motion to Dismiss Pending / Under Review
REQUEST for Oral Argument by Mylan Inc., Mylan Pharmaceuticals Inc. re 14 MOTION to Dismiss for Lack of Jurisdiction Over the Person . (Moore, David) (Entered: ...
Entry #25 • 2014-10-13 Document →

Docket Entries

(63 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1537648.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg) (Entered: 06/20/2014)

Entry #1 • 2014-06-19
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1537648.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg) (Entered: 06/20/2014)

Entry #1 • 2014-06-19
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1537648.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg) (Entered: 06/20/2014)

Entry #1 • 2014-06-19
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1537648.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(etg) (Entered: 06/20/2014)

Entry #1 • 2014-06-19
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (etg) (Entered: 06/20/2014)

Entry #2 • 2014-06-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc